BackPanbela Therapeutics Overview

Panbela Therapeutics Current Cash

Track Panbela Therapeutics's current cash ($140K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$142000.00
↓ 84.34% YoYΔ $-765000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Panbela Therapeutics Current Cash History

Loading

Panbela Therapeutics vs. peers: Current Cash Comparison

Loading

Panbela Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Panbela Therapeutics (PBLA) FAQ

Panbela Therapeutics (PBLA) currently reports a current cash of $140K as of September 2024. That compares with $910K in the prior-year period — down 84.3% year over year. Use the charts on this page to explore Panbela Therapeutics's current cash history and peer comparisons.

Panbela Therapeutics's current cash decreased from $910K to $140K — a 84.3% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Panbela Therapeutics reported $140K in current cash as of September 2024. That compares with $910K in the prior-year period — down 84.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $140K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Panbela Therapeutics, and consider following PBLA for alerts when major investors trade the stock.

Panbela Therapeutics is classified in the Technology sector. On current cash, it currently shows $140K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing PBLA with unrelated industries.